TCM
Telos Capital Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Sell |
19,876
-337
| -2% | -$62.6K | 0.38% | 81 |
|
|
2025
Q1 | $4.24M | Sell |
20,213
-2,738
| -12% | -$574K | 0.46% | 77 |
|
|
2024
Q4 | $4.08M | Sell |
22,951
-1,380
| -6% | -$245K | 0.44% | 78 |
|
|
2024
Q3 | $4.8M | Sell |
24,331
-642
| -3% | -$127K | 0.5% | 76 |
|
|
2024
Q2 | $4.28M | Sell |
24,973
-454
| -2% | -$77.9K | 0.47% | 76 |
|
|
2024
Q1 | $4.63M | Sell |
25,427
-25,808
| -50% | -$4.7M | 0.52% | 75 |
|
|
2023
Q4 | $7.94M | Buy |
51,235
+437
| +0.9% | +$67.7K | 0.97% | 34 |
|
|
2023
Q3 | $7.57M | Buy |
50,798
+900
| +2% | +$134K | 1.05% | 31 |
|
|
2023
Q2 | $6.72M | Sell |
49,898
-489
| -1% | -$65.9K | 0.9% | 35 |
|
|
2023
Q1 | $8.03M | Sell |
50,387
-3,952
| -7% | -$630K | 1.12% | 29 |
|
|
2022
Q4 | $8.78M | Buy |
54,339
+199
| +0.4% | +$32.2K | 1.28% | 21 |
|
|
2022
Q3 | $7.27M | Buy |
54,140
+164
| +0.3% | +$22K | 1.2% | 23 |
|
|
2022
Q2 | $8.27M | Sell |
53,976
-563
| -1% | -$86.2K | 1.26% | 19 |
|
|
2022
Q1 | $8.84M | Sell |
54,539
-1,765
| -3% | -$286K | 1.15% | 27 |
|
|
2021
Q4 | $7.62M | Sell |
56,304
-1,460
| -3% | -$198K | 0.95% | 35 |
|
|
2021
Q3 | $6.23M | Sell |
57,764
-14,997
| -21% | -$1.62M | 0.85% | 38 |
|
|
2021
Q2 | $8.2M | Sell |
72,761
-440
| -0.6% | -$49.6K | 1.08% | 29 |
|
|
2021
Q1 | $7.92M | Buy |
73,201
+33
| +0% | +$3.57K | 1.14% | 25 |
|
|
2020
Q4 | $7.84M | Sell |
73,168
-3,919
| -5% | -$420K | 1.19% | 25 |
|
|
2020
Q3 | $6.75M | Sell |
77,087
-462
| -0.6% | -$40.5K | 1.18% | 21 |
|
|
2020
Q2 | $7.61M | Buy |
77,549
+6,330
| +9% | +$621K | 1.47% | 18 |
|
|
2020
Q1 | $5.43M | Buy |
71,219
+48,658
| +216% | +$3.71M | 1.34% | 19 |
|
|
2019
Q4 | $2M | Buy |
22,561
+13,802
| +158% | +$1.22M | 0.46% | 75 |
|
|
2019
Q3 | $664K | Buy |
+8,759
| New | +$664K | 0.18% | 103 |
|